Yoshitaka Isaka

Osaka University Graduate School of Medicine
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Chronic kidney disease (CKD) is a global health crisis affecting over 10% of the population, with mortality rates increasing significantly. Current management strategies, including expensive medications and renal replacement therapies, highlight the need for cost-effective, conservative approaches. This review examines the evidence for plant-dominant low-protein diets (PLADO) in managing non-dialysis-dependent CKD. Existing guidelines for protein restriction in CKD vary considerably, with inconsistencies and a lack of personalization noted in the KDOQI and KDIGO recommendations. While traditional low-protein diet trials show limited success due to poor adherence and marginal benefits, PLADO offers a potentially more sustainable alternative. PLADO’s advantages include improved nutrient density, reduced dietary acid load, anti-inflammatory effects, and beneficial modulation of the gut microbiome, potentially reducing uremic toxins and improving cardiovascular health. However, challenges remain, including adherence issues, potential nutrient deficiencies, and potassium management. Although observational studies show promise, further large-scale randomized controlled trials are necessary to validate PLADO’s efficacy and establish optimal dietary composition. A personalized, multidisciplinary approach is essential for successful implementation and monitoring to maximize PLADO’s benefits in improving outcomes for individuals with NDD-CKD.

Year:

2025

Background Measurement of glomerular filtration rate (GFR) is subject to inaccurate urine collection. Clearances of d-serine and d-asparagine, rare enantiomers of amino acids, are the measures of GFR since they are almost free of tubular secretion and reabsorption. We hypothesize that d-serine and d-asparagine can accurately determine urine volume and GFR. Methods This cross-sectional observational study included 209 living kidney transplant donors and recipients for whom GFR was measured using the clearance of inulin. Assuming that urine excretions of d-serine and d-asparagine are constant and using urine levels of d-serine and d-asparagine from each urine collection, an equation for estimated urine volume (eUV) was established. Based on the eUV, the abnormal urine volume was replaced with an estimate with which the GFR was re-evaluated. Result Clearances of d-serine and d-asparagine were minor in proportional biases when compared with that of creatinine. Using 627 urine collections, the equation for eUV (mL/min) was established as 21.88/urine d-Ser(0.40 + 0.20 × log10(urine d-Asn)). Using eUV, we identified 20 instances where urine collection volumes varied significantly from the estimated values. After replacement with eUV, measured GFR (mGFR) was corrected to adjusted mGFR, which was within approximately 20 mL/min/1.73 m2 of the mGFR. Conclusion d-Serine and d-asparagine are nearly completely excreted in urine after glomerular filtration, enabling the estimation of urine volume and correct mGFR. Besides reflecting GFR, d-serine and d-asparagine can be used to estimate urine volume. By applying the eUV method, mGFR determined using clearance methods becomes more accurate.

Year:

2024

Autoimmune rheumatic diseases present with diverse clinical manifestations that often complicate management strategies. Systemic sclerosis (SSc) is a representative disease with multiple organ manifestations affecting patients worldwide, and exploring the variation of immune abnormalities in this disease is of great interest. However, previous studies have focused on diseased tissues, and it remains largely unknown how cellular diversity links to clinical heterogeneity. Here, we perform single-cell transcriptome and surface proteome analyses of peripheral blood mononuclear cells (PBMCs) from 21 SSc patients who are not receiving immunomodulatory therapy and show that different clinical manifestations are associated with distinct immune abnormalities. Enrichment of a specific CD14 + monocyte subset characterized by EGR1 expression is observed in patients with scleroderma renal crisis (SRC). Integrated analysis of PBMCs and kidney biopsy cells indicates that this monocyte subset directly differentiates into tissue-damaging macrophages under activation of NF-κB signaling. Clinically, EGR1 expression in monocytes is significantly upregulated at the onset of SRC and decreases after treatment, suggesting its potential as a biomarker for SRC. In patients with interstitial lung disease (ILD), a CD8 + T cell subset with type II interferon signature is highly enriched in both peripheral blood and lung tissue of patients with progressive disease, suggesting that chemokine-driven migration of these cells is involved in ILD progression. Thus, distinct immune cell profiles at the single cell level reveal different directions of immune dysregulation between organ manifestations and provide insights for tailored treatment strategies.

Year:

2024

Fatty acid β-oxidation (FAO) plays a key role in energy homeostasis. Here, the authors established a strategy for visualizing FAO activity in vivo at the cellular-level spatial resolution and seconds-level time resolution in mice. Quantitative analysis revealed spatiotemporal heterogeneity in hepatic FAO dynamics. Our method is widely applicable because it is simple and uses a multiphoton microscope to observe the FAOBlue-injected mice.

Year:

2023

Collaborators (6)

Yusuke Sakaguchi

Osaka University

JAPAN
View details

Masayuki Nishide

Osaka University

JAPAN
View details

Atsushi Kumanogoh

Professor

Osaka University Graduate School of Medicine

JAPAN
View details

Masayuki Mizui

Osaka University Graduate School of Medicine

JAPAN
View details

Yukinori Okada

University of Tokyo

JAPAN
View details

Tomonori Kimura

Osaka University Graduate School of Medicine

JAPAN
View details